The early onset of menopause is a known risk factor for primary open angle glaucoma (POAG) with the associated hormonal changes seeming to play an important role. This begged the question of whether postmenopausal hormone therapy could actually play a role in reducing the risk of glaucoma and act in a protective fashion.

Research on Glaucoma Risk & Postmenopausal Hormones

According to researchers publishing in JAMA Ophthalmology taking estrogen only postmenopausal hormone (PMH) treatment may help reduce the risk for primary open-angle glaucoma (POAG). By reviewing data from 152,163 women 50 years or older the researchers found that 1.9 percent of enrollees developed POAG. Each additional month of use of PMH containing estrogen only was associated with a 0.4 percent reduced risk for POAG whereas each additional month of use of estrogen + progesterone or estrogen + androgen hormones did not affect risk for POAG. This is interesting information and will require further clinical studies to understand fully but may offer some novel treatments for primary open angle glaucoma (POAG), an insidious sight threatening eye diseases and the most common type of glaucoma.

If you or someone you know has questions about glaucoma, glaucoma risk factors and the role of postmenopausal hormone therapy in glaucoma risk, or needs to schedule an appointment, please call The Eye Clinic of Texas, an affiliate of Houston Eye Associates, at 800-423-3937, visit The Eye Clinic of Texas or facebook.com/ecot.lasik. The Eye Clinic of Texas is an affiliate of Houston Eye Associates, the largest ophthalmology clinic in the nation. We are a leading eye care practice serving the greater Houston, Galveston, League City and Texas City with offices at 1100 Gulf Freeway, Suite 114, League City, Texas 77573, 7111 Medical Center Drive, Suite 110, Texas City, Texas 77590 and 2302 Avenue P, Galveston, Texas.

Patients who suffer from sleep apnea may be at greater risk of glaucoma. What do sleep apnea and your risk of developing glaucoma have in common? Sleep apnea is a chronic condition that blocks breathing during sleep for more than 100 million people worldwide. In obstructive sleep apnea, the airway becomes blocked, causing breathing to stop for up to two minutes. Symptoms include loud snoring and persistent daytime sleepiness. Glaucoma affects nearly 60 million worldwide.  If untreated, glaucoma reduces peripheral vision and eventually may cause blindness by damaging the optic nerve. Only half of the people who have glaucoma are aware of it because the disease is painless and vision loss is typically gradual. Researchers, reporting in the journal Ophthalmology, the official publication of the American Academy of Ophthalmology found that obstructive sleep apnea is not simply a marker for poor health, but is actually an independent risk factor for open-angle glaucoma. The relationship between the two conditions is significant, given the large numbers of people worldwide who suffer from them. Based on this finding, we want to alert obstructive sleep apnea patients of the associations between obstructive sleep apnea and open-angle glaucoma to raise the issue and encouraging treatment of those who need it.

If you or someone you know suffers from sleep apnea you may be at greater risk of glaucoma and need to have regular eye exams. Please call The Eye Clinic of Texas, an affiliate of Houston Eye Associates, at 800-423-3937, visit The Eye Clinic of Texas or facebook.com/ecot.lasik to schedule an appointment.

The Eye Clinic of Texas is an affiliate of Houston Eye Associates, the largest ophthalmology clinic in the nation. We are a leading eye care practice serving the greater Houston, Galveston, League City and Texas City with offices at 1100 Gulf Freeway, Suite 114, League City, Texas 77573, 7111 Medical Center Drive, Suite 110, Texas City, Texas 77590 and 2302 Avenue P, Galveston, Texas 77550.